Partnering with ASN
Partner with ASN and gain direct access to the nephrology community.
Partnership opportunities include:
- Supporting ASN education, which takes place at conferences and via enduring material.
- Advertising in ASN-sponsored journals and publications.
- Exhibiting at ASN's annual conference—Kidney Week—which is the largest kidney meeting in the world.
- Supporting promotional opportunities throughout the year.
ASN Corporate Supporters
The ASN Corporate Support Program recognizes supporters year round for their generous contributions to the Society. Through this program, supporters help ASN lead the fight against kidney diseases. ASN gratefully acknowledges the following companies for their contributions in 2020.
For more specific information, please click here.
To learn about ASN's Conflict of Interest Initiative, please click here.
- Alexion Pharmaceuticals, Inc.
- Baxter Healthcare Corporation
- Cara Therapeutics, Inc.
- ChemoCentryx, Inc.
- Horizon Therapeutics
- Mallinckrodt LLC
- OPKO Renal
- Relypsa, A Vifor Pharma Group Company
- Retrophin, Inc.
- Sanofi Genzyme
- Ultragenyx Pharmaceutical
- Vertex Pharmaceuticals Inc.
- Alnylam Pharmaceuticals, Inc.
- Amicus Therapeutics
- Aurinia Pharmaceuticals
- Boehringer Ingelheim
- Bristol Myers Squibb
- Chiesi USA, Inc.
- Janssen Pharmaceuticals, Inc.
- Omeros Corporation
- Outset Medical
- Rockwell Medical
Vice President of Business Development
American Society of Nephrology